BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36395984)

  • 1. Bronchial epithelial cell transcriptome shows endotype heterogeneity of asthma in patients with NSAID-exacerbated respiratory disease.
    Jakiela B; Soja J; Sladek K; Przybyszowski M; Plutecka H; Gielicz A; Licholai S; Aab A; Rebane A; Bochenek G
    J Allergy Clin Immunol; 2023 Apr; 151(4):953-965. PubMed ID: 36395984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease.
    Jakiela B; Soja J; Sladek K; Przybyszowski M; Plutecka H; Gielicz A; Rebane A; Bochenek G
    J Allergy Clin Immunol; 2021 Apr; 147(4):1269-1280. PubMed ID: 32810516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex, Ethnicity, Body Mass Index, and Environmental Exposures Associated With NSAID-Exacerbated Respiratory Disease Symptom Sequence.
    Dages KN; Sofola-James O; Sehanobish E; Regula P; Chen CC; Chiarella SE; Divekar RD; Cohen HW; Jerschow E
    J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3662-3669.e2. PubMed ID: 37541619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).
    Cousins K; Chen CC; Sehanobish E; Jerschow E
    Adv Pharmacol; 2023; 97():423-444. PubMed ID: 37236766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Omalizumab in NSAID-Exacerbated Respiratory Disease: A Narrative Review.
    Taniguchi M; Heffler E; Olze H; White A; Côrte-Real J; Olsson P; Lazarewicz S
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2570-2578. PubMed ID: 35764285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.
    Kowalski ML; Agache I; Bavbek S; Bakirtas A; Blanca M; Bochenek G; Bonini M; Heffler E; Klimek L; Laidlaw TM; Mullol J; Niżankowska-Mogilnicka E; Park HS; Sanak M; Sanchez-Borges M; Sanchez-Garcia S; Scadding G; Taniguchi M; Torres MJ; White AA; Wardzyńska A
    Allergy; 2019 Jan; 74(1):28-39. PubMed ID: 30216468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
    Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
    Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Biomarkers for NSAID-Exacerbated Respiratory Disease.
    Park H; Choi Y; Jung CG; Park HS
    Mediators Inflamm; 2017; 2017():8160148. PubMed ID: 28852271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.
    Haimerl P; Bernhardt U; Schindela S; Henkel FDR; Lechner A; Zissler UM; Pastor X; Thomas D; Cecil A; Ge Y; Haid M; Prehn C; Tokarz J; Heinig M; Adamski J; Schmidt-Weber CB; Chaker AM; Esser-von Bieren J
    J Allergy Clin Immunol; 2021 Feb; 147(2):587-599. PubMed ID: 32540397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease in absence of corticosteroids.
    Bartosik TJ; Campion NJ; Freisl K; Liu DT; Gangl K; Stanek V; Tu A; Pjevac P; Hausmann B; Eckl-Dorna J; Schneider S
    Front Immunol; 2023; 14():1112345. PubMed ID: 37122714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of NSAID-Exacerbated Respiratory Disease: has the time come for subphenotyping?
    Kowalski ML
    Curr Opin Pulm Med; 2019 Jan; 25(1):64-70. PubMed ID: 30489335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis.
    Stevens WW; Peters AT; Tan BK; Klingler AI; Poposki JA; Hulse KE; Grammer LC; Welch KC; Smith SS; Conley DB; Kern RC; Schleimer RP; Kato A
    J Allergy Clin Immunol Pract; 2019; 7(8):2812-2820.e3. PubMed ID: 31128376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial neural network identifies nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD) cohort.
    Tyrak KE; Pajdzik K; Konduracka E; Ćmiel A; Jakieła B; Celejewska-Wójcik N; Trąd G; Kot A; Urbańska A; Zabiegło E; Kacorzyk R; Kupryś-Lipińska I; Oleś K; Kuna P; Sanak M; Mastalerz L
    Allergy; 2020 Jul; 75(7):1649-1658. PubMed ID: 32012310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis.
    Celejewska-Wójcik N; Wójcik K; Ignacak-Popiel M; Ćmiel A; Tyrak K; Gielicz A; Kania A; Nastałek P; Sanak M; Mastalerz L
    Allergy; 2020 Apr; 75(4):831-840. PubMed ID: 31803947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the effects of vitamin D Level on airway obstruction in two asthma endotypes in humans and in two mouse models with different intake of vitamin D during early-life.
    Zhou Y; Qiu Y; Bao W; Han L; Xue Y; Zhang Y; Tian X; Fu Q; Lv C; Yin D; Zhang M
    Front Immunol; 2023; 14():1107031. PubMed ID: 36793727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
    Tyrak KE; Kupryś-Lipińska I; Czarnobilska E; Jakieła B; Pajdzik K; Ćmiel A; Plutecka H; Koziej M; Gawrońska A; Konduracka E; Kuna P; Sanak M; Mastalerz L
    Respir Med; 2019 Jun; 152():51-59. PubMed ID: 31128610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inheritance of NSAID-Exacerbated Respiratory Disease.
    Suikkila A; Lyly A; Hafrén L; Saarinen R; Klockars T
    Otolaryngol Head Neck Surg; 2023 Mar; 168(3):540-543. PubMed ID: 35639475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Tan JHY; Hsu AAL
    Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-eosinophilic asthma in nonsteroidal anti-inflammatory drug exacerbated respiratory disease.
    Mastalerz L; Celejewska-Wójcik N; Ćmiel A; Wójcik K; Szaleniec J; Hydzik-Sobocińska K; Tomik J; Sanak M
    Clin Transl Allergy; 2023 Mar; 13(3):e12235. PubMed ID: 36973957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchial thermoplasty in asthma: an exploratory histopathological evaluation in distinct asthma endotypes/phenotypes.
    Papakonstantinou E; Koletsa T; Zhou L; Fang L; Roth M; Karakioulaki M; Savic S; Grize L; Tamm M; Stolz D
    Respir Res; 2021 Jun; 22(1):186. PubMed ID: 34183014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.